SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nuri Danisman, Serkan Kahyaoglu, Sevki Celen, Inci Kahyaoglu, Zuhal Candemir, Ahmet Yesilyurt, Esra Sukran Cakar, A retrospective analysis of amniocenteses performed for advanced maternal age and various other indications in Turkish women, Journal of Maternal-Fetal and Neonatal Medicine, 2013, 26, 3, 242

    CrossRef

  2. 2
    J. Goffette, Diagnostic anténatal et eugénisme : réflexions philosophiques et historiques, Revue de médecine périnatale, 2013, 5, 3, 164

    CrossRef

  3. 3
    George Seow Heong Yeo, Fon-Min Lai, Xing Wei, Padma Lata, Doreen Tsai Hia Tan, Min Hwee Yong, Edward Teck Hoo Tan, Kenneth Yung Chiang Kwek, Validation of First Trimester Screening for Trisomy 21 in Singapore with Reference to Performance of Nasal Bone, Fetal Diagnosis and Therapy, 2012, 32, 3, 166

    CrossRef

  4. You have free access to this content4
    Kypros H. Nicolaides, Screening for fetal aneuploidies at 11 to 13 weeks, Prenatal Diagnosis, 2011, 31, 1
  5. 5
    Emanuele Leoncini, Lorenzo D. Botto, Guido Cocchi, Goran Annerén, Carol Bower, Jane Halliday, Emmanuelle Amar, Marian K. Bakker, Sebastiano Bianca, Maria Aurora Canessa Tapia, Eduardo E. Castilla, Melinda Csáky-Szunyogh, Saeed Dastgiri, Marcia L. Feldkamp, Miriam Gatt, Fumiki Hirahara, Danielle Landau, R. Brian Lowry, Lisa Marengo, Robert McDonnell, Triphti M. Mathew, Margery Morgan, Osvaldo M. Mutchinick, Anna Pierini, Simone Poetzsch, Annukka Ritvanen, Gioacchino Scarano, Csaba Siffel, Antonin Sípek, Elena Szabova, Giovanna Tagliabue, Stein Emil Vollset, Wladimir Wertelecki, Ludmila Zhuchenko, Pierpaolo Mastroiacovo, How valid are the rates of Down syndrome internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and Research, American Journal of Medical Genetics Part A, 2010, 152A, 7
  6. 6
    T. Rousseau, C. Ferdynus, C. Thauvin-Robinet, J.-B. Gouyon, P. Sagot, Impact des variations de distribution de l’âge maternel sur la prévalence attendue à la naissance de la trisomie 21 en France métropolitaine entre 1965 et 2008, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2010, 39, 4, 284

    CrossRef

  7. 7
    T. Rousseau, E. Amar, C. Ferdynus, C. Thauvin-Robinet, J.-B. Gouyon, P. Sagot, Variations de prévalence de la trisomie 21 en population française entre 1978 et 2005, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2010, 39, 4, 290

    CrossRef

  8. 8
    Yury Verlinsky, Nicolas H. Zech, Nikolai Strelchenko, Valeri Kukharenko, Artem Shkumatov, Zev Zlatopolsky, Anver Kuliev, Correlation between preimplantation genetic diagnosis for chromosomal aneuploidies and the efficiency of establishing human ES cell lines, Stem Cell Research, 2009, 2, 1, 78

    CrossRef

  9. 9
    J. Belaisch-Allart, Embarazo y parto después de los 40 años, EMC - Ginecología-Obstetricia, 2008, 44, 3, 1

    CrossRef

  10. 10
    Valerie Seror, Fitting observed and theoretical choices – women's choices about prenatal diagnosis of Down syndrome, Health Economics, 2008, 17, 5
  11. 11
    J. Belaisch-Allart, Grossesse et accouchement après 40 ans, EMC - Obstétrique, 2008, 3, 2, 1

    CrossRef

  12. 12
    Darija M. Strah, Maja Pohar, Ksenija Gersak, Risk assessment of trisomy 21 by maternal age and fetal nuchal translucency thickness in 7096 unselected pregnancies in Slovenia, Journal of Perinatal Medicine, 2008, 36, 2

    CrossRef

  13. 13
    J. Sabriá Rius, C. Bach Vallmajor, J. Sabriá Bach, E. Sabriá Bach, Ecografía en diagnóstico prenatal, 2008,

    CrossRef

  14. 14
    Ernest B. Hook, Rates of Down syndrome at the upper extreme of maternal age: considerations and recommendations in analysis, Prenatal Diagnosis, 2006, 26, 6
  15. 15
    Kyriaki Avgidou, Aris Papageorghiou, Renu Bindra, Kevin Spencer, Kypros H. Nicolaides, Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies, American Journal of Obstetrics and Gynecology, 2005, 192, 6, 1761

    CrossRef

  16. 16
    C. Bach, S. Torrent, D. Cabrero, J. Sabrià, Cribado bioquímico-ecográfico de las aneuploidías en el primer trimestre. Metodología y resultados, Progresos de Obstetricia y Ginecología, 2004, 47, 1, 5

    CrossRef

  17. 17
    Kypros H. Nicolaides, Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities, American Journal of Obstetrics and Gynecology, 2004, 191, 1, 45

    CrossRef

  18. 18
    William Cusick, Philip Buchanan, Terrence W. Hallahan, David A Krantz, John W. Larsen, James N. Macri, Combined first-trimester versus second-trimester serum screening for Down syndrome: A cost analysis, American Journal of Obstetrics and Gynecology, 2003, 188, 3, 745

    CrossRef

  19. 19
    J. K. Morris, N. J. Wald, D. E. Mutton, E. Alberman, Comparison of models of maternal age-specific risk for Down syndrome live births, Prenatal Diagnosis, 2003, 23, 3
  20. 20
    Peter A. Benn, Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing, Clinica Chimica Acta, 2002, 323, 1-2, 1

    CrossRef

  21. 21
    Kypros H. Nicolaides, Victoria Heath, Simona Cicero, Increased fetal nuchal translucency at 11–14 weeks, Prenatal Diagnosis, 2002, 22, 4
  22. 22
    Severin Olesen Larsen, Jan Hansen, Bent Nørgaard Pedersen, Expected, prenatally discovered, and born cases of Down syndrome in Denmark during the period 1980–1998, Prenatal Diagnosis, 2001, 21, 8
  23. 23
    Ernest B. Hook, Maternal age-specific rates of Down syndrome used in serum screening are biased low, Prenatal Diagnosis, 2000, 20, 2
  24. 24
    Peter A. Benn, James F. X. Egan, Survival of Down syndrome in utero, Prenatal Diagnosis, 2000, 20, 5
  25. 25
    Thomas C. Winter, Stefanie B. Uhrich, Vivienne L. Souter, David A. Nyberg, The “Genetic Sonogram”: Comparison of the Index Scoring System with the Age-adjusted US Risk Assessment1, Radiology, 2000, 215, 3, 775

    CrossRef

  26. 26
    Howard Cuckle, Down syndrome fetal loss rate in early pregnancy, Prenatal Diagnosis, 1999, 19, 12
  27. 27
    A.D. Carothers, E. Boyd, G. Lowther, P.M. Ellis, D.A. Couzin, M.J.W. Faed, A. Robb, Trends in prenatal diagnosis of Down syndrome and other autosomal trisomies in Scotland 1990 to 1994, with associated cytogenetic and epidemiological findings, Genetic Epidemiology, 1999, 16, 2
  28. 28
    Andrew I. Sokol, Ralph L. Kramer, Yuval Yaron, Joseph E. O’Brien, Francoise Muller, Mark P. Johnson, Mark I. Evans, Age-specific variation in aneuploidy incidence among biochemical screening programs, American Journal of Obstetrics and Gynecology, 1998, 179, 4, 971

    CrossRef

  29. 29
    Valérie Seror, Nathalie Costet, Down syndrome serum marker screening: decision criteria and implicit values, Health Policy, 1998, 43, 1, 83

    CrossRef

  30. 30
    H. S. Cuckle, Effect of maternal age curve on the predicted detection rate in maternal serum screening for Down syndrome, Prenatal Diagnosis, 1998, 18, 11
  31. 31
    Isabelle Bray, David E. Wright, Chris Davies, Ernest B. Hook, Joint estimation of Down syndrome risk and ascertainment rates: a meta-analysis of nine published data sets, Prenatal Diagnosis, 1998, 18, 1
  32. 32
    Bor-Ching Sheu, Ming-Kwang Shyu, Chien-Nan Lee, Bo-Jein Kuo, Yun-Ying Tseng, Fon-Jou Hsieh, Maternal age-specific risk of Down syndrome in an Asian population: a report of the Taiwan Down syndrome screening group, Prenatal Diagnosis, 1998, 18, 7
  33. 33
    RJM Snijders, P Noble, N Sebire, A Souka, KH Nicolaides, UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation, The Lancet, 1998, 352, 9125, 343

    CrossRef

  34. 34
    Ernest B. Hook, Andrew D. Carothers, Use of computer simulation to evaluate a putative cluster of genetic or teratologic outcomes: Adjustment for “multiple hypotheses” and application to a reported excess of Down's syndrome, Genetic Epidemiology, 1997, 14, 2
  35. 35
    Christina August Hecht, Ernest B. Hook, Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: A proposed revised rate schedule for use in genetic and prenatal screening, American Journal of Medical Genetics, 1996, 62, 4
  36. 36
    Jane L. Halliday, Lyndsey F. Watson, Judith Lumley, David M. Danks, Leslie J. Sheffield, New estimates of down syndrome risks at chorionic villus sampling, amniocentesis, and livebirth in women of advanced maternal age from a uniquely defined population, Prenatal Diagnosis, 1995, 15, 5